Biotech

Missiles, cars, leather … finally, biotech pushes pills

By GREGORY ZELLER // A biotech with a penchant for leather, foreign automobiles, high-tech weaponry and next-gen digital imaging is finally getting around to pharmaceuticals. Actually, that’s not true – Stony Brook-based Applied DNA Sciences has already this year announced multiple pharma-nutra-focused forays, including the production of DNA chains for in-vitro diagnostic and DNA-based therapeutic research purposes. But in announcing a technology license memorandum of understanding with Pennsylvania-based “hard dose” specialist Colorcon Inc., Applied DNA…


CSHL conference lands a bull’s eye on Lyme detection

By GREGORY ZELLER // A gaggle of academic, public health and commercial-healthcare specialists gathered under Cold Spring Harbor Laboratory’s mighty banner have published findings that could rewrite the book on Lyme disease detection. When the laboratory-diagnostics experts convened for a 2016 Banbury Center meeting – such gatherings, held at CSHL’s on-campus think tank, are generally regarded among the best international scientific workshops – they focused on Lyme, and specifically, earlier detection of a disease that…


Applied DNA is talking Turkey (and West Africa, too)

By GREGORY ZELLER // Applied DNA Sciences is in one of those modes again: another week, another big leap into a potentially lucrative geographic or vertical market. This week, it’s geographic, with a new federal mandate in the Republic of Turkey aiding the Stony Brook biotech’s efforts to develop new business there. Applied DNA on Tuesday announced plans to introduce DNA-tagged fertilizer to Turkey and countries in West Africa and Asia, amidst strong interest in…


As biopharma blossoms, ace DNA producer locks in

By GREGORY ZELLER // Applied DNA Sciences has long proclaimed textiles – your cotton shirt, your leather shoes and the industries that produce them – as its primary vertical market, the ideal sector in which to apply its patented DNA-based security and authentication protocols. But a wholly different use for its coveted DNA supplies may soon eclipse textile-tracking as the Stony Brook biotech’s primary moneymaker. That’s the word from President and CEO James Hayward, who…


Defense Logistics Agency re-ups on DNA markers

A federal contract extension will keep Applied DNA Sciences knee-deep in microcircuits for another year at least. The Stony Brook biotech said Monday that the Defense Logistics Agency has awarded a one-year extension of a 2014 deal through which the supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist applies its SigNature DNA biomarkers to microcircuits at the DLA’s Ohio-based Land and Maritime facility. Financial terms of the contract extension were not disclosed. But continuing to mark and…


Applied DNA earns new SigNature patent, more T’d up

By GREGORY ZELLER // Applied DNA Sciences has added two new U.S. patents to its impressive collection – at least, a new patent-and-a-half. The Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist announced this week the arrival of U.S. Patent No. 9,790,538, covering “Alkaline Activation for Immobilization of DNA Taggants” – essentially, protecting the core technology powering Applied DNA’s SigNature T molecular tags. The biotech also announced a Notice of Allowance on U.S. Patent Application…


With license and library deals, biotech spreads its DNA

By GREGORY ZELLER // It’s been a banner month for Applied DNA Sciences, with two new deals both reaffirming the biotech’s scientific value and significantly extending its commercial reach. On Friday, the provider of DNA-focused supply chain, anti-counterfeiting and anti-theft technologies announced that its SigNature molecular tag technology had been added to global materials-innovator Material ConneXion’s prestigious library – exposing Applied DNA’s wares to scientists, manufacturers and makers around the world, a potentially enormous commercial…


Codagenix scores again: $3M to hunt down deadly RSV

By GREGORY ZELLER // A fresh $3 million in public and private investments has set Codagenix Inc. on the trail of another nefarious disease. Already developing vaccines for Zika virus, the mutating menace Influenza A and a host of other viral villains, Codagenix will now focus its vaccine-creation might on Respiratory Syncytial Virus through a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health and another $1.5 million in…


In REDC love fest, CSHL kicks off $75M makeover

By GREGORY ZELLER // There was another major advance for biochemistry Thursday at Cold Spring Harbor Laboratory, but this one didn’t involve gas chromatographs or infrared spectrometers or a single test tube. Just a shovel. With Gov. Andrew Cuomo and a host of regional and state representatives on hand, the world-class scientific research facility officially broke ground on the renovation of its Demerec Laboratory, one of four CSHL laboratories being remade with a big assist…


NIH sees a need for speed in Traverse Biosciences

By GREGORY ZELLER // The National Institutes of Health has welcomed a rising Stony Brook biotech into its competitive Commercialization Accelerator Program. Traverse Biosciences, which is attempting to commercialize novel drug candidates for the treatment of inflammatory diseases affecting animals and humans, has landed one of 80 annual slots in the CAP, a nine-month program hosted by the NIH and the Larta Institute, a California-based networking group promoting international innovation. The NIH CAP – which…


Printing partnership takes Applied DNA global, again

By GREGORY ZELLER // Diversity-driven Stony Brook biotech Applied DNA Sciences has added yet another vertical market to its rapidly expanding collection: laser printers. And not just printers and inks but third parties that use them to tag their products, packaging and supply-chain components, all available through a new “strategic partnership” between Applied DNA and Videojet Technologies. Under the guidance of an all-star business-development team, the biotech – which specializes in can’t-be-copied, can’t-be-broken DNA-based security…


Feds back NYIT professors on RNA-sequencing quest

By GREGORY ZELLER // Diverse disciplines are coming together at NYIT, where a multi-year National Institutes of Health grant is fueling next-level RNA research – and, possibly, opening a new front in the war against cancer. Two New York Institute of Technology faculty members, assistant professors of life sciences and computer sciences, will combine their skills under a three-year, $568,000 Cutting Edge Basic Research award from the NIH’s National Human Genome Research Institute. Their mission:…


Startup sails past $1M, considers second employee

By GREGORY ZELLER // A key e-commerce alliance has pushed an innovative skin-care company past $1 million in revenues – and has the biotech’s only full-time employee thinking expansion, in more ways than one. Kantian Skincare, a 2012 startup and the public face of Huntington-based Kantian Sciences Corp., hurtled past the $1 million plateau in July, according to cofounder and President Jon Klein, on the back of the Neutralyze Anti-Acne Solution, the company’s flagship product….


Re-Nuble targets USDA over ‘organic’ certifications

By GREGORY ZELLER // A “waste-to-value” biotech with Long Island roots is taking its food-for-all message to the people – and is taking on the U.S. Department of Agriculture over critical “organic” certifications. Re-Nuble Inc., which operates out of facilities in Brooklyn and Long Island City but remains a “virtual tenant” of Stony Brook University’s Clean Energy Business Incubator Program, is presenting Wednesday at Food Tank Summit NYC, a celebration and exploration of food and…


Applied DNA enlists with Army’s bio-warfare defenders

By GREGORY ZELLER // Applied DNA Sciences is in the Army now. Already under U.S. Department of Defense contract on a number of different projects, the Stony Brook-based biotech has entered into a new Cooperative Research and Development Agreement with U.S. Army Research, Development and Engineering Command’s Edgewood Chemical Biological Center. Best known as a developer and distributor of in-house botanical-DNA-based security and authentication protocols, Applied DNA is lending its expertise in a slightly different…